Zobrazeno 1 - 10
of 110
pro vyhledávání: '"D. Eshima"'
Publikováno v:
Hypertension. 23:96-103
The clearance of [131I]orthoiodohippurate and 99mTc-mercaptoacetyltriglycine provide a measure of effective renal plasma flow, yet these clearances are proportional to renal plasma flow only if the extraction fraction remains constant. To determine t
Autor:
P. D'Souza, N.A. Matwiyoff, R. Purvis, R. Wenk, D.G. Baughman, P.L. Mann, S.M. Quesada, J.L. Born, D. Eshima, D.M. Bitner
Publikováno v:
Nuclear Medicine and Biology. 20:203-210
Traditional tumor imaging with biotracer techniques relies solely on the target specificity of the biomolecule. We hypothesize that specific imaging is possible by altering the rate of tissue clearance (both normal and aberrant) of any given radiotra
Autor:
T A, Deterding, J R, Votaw, C K, Wang, D, Eshima, L, Eshima, R, Keil, E, Malveaux, C D, Kilts, M M, Goodman, J M, Hoffman
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 42(2)
18F-labeled 2 beta-carbomethoxy-3beta-(4-chlorophenyl)-8-(-2-fluoroethyl)nortropane ([18F]FECNT) is a recently developed dopamine transporter ligand with potential applications in patients with Parkinson's disease and cocaine addiction.Estimates of t
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 41(12)
The clearance of 99mTc-mercaptoacetyltriglycine (MAG3) is less than the clearances of o-131I-iodohippurate (OIH) and 99mTc-labeled DD- and LL-ethylenedicysteine (EC). This difference could be associated with the lower affinity of MAG3 for the tubular
Synthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors
Autor:
T M, Shoup, J, Olson, J M, Hoffman, J, Votaw, D, Eshima, L, Eshima, V M, Camp, M, Stabin, D, Votaw, M M, Goodman
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 40(2)
We have developed a new tumor-avid amino acid, 1-amino-3-fluorocyclobutane-1-carboxylic acid (FACBC), labeled with 18F for nuclear medicine imaging.[18F]FACBC was prepared with high specific activity (no carrier added [NCA]) and was evaluated for its
Autor:
A, Taylor, L, Hansen, D, Eshima, E, Malveaux, R, Folks, L, Shattuck, M, Lipowska, L G, Marzilli
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 38(5)
Technetium-99m-L,L-ethylenedicysteine (99mTc-LL-EC) is a new renal imaging agent with pharmacokinetic properties reported to be slightly superior to those of 99mTc-mercaptoacetyltriglycine (99mTc-MAG3); however, to better define the potential of the
Autor:
M M, Goodman, R, Keil, T M, Shoup, D, Eshima, L, Eshima, C, Kilts, J, Votaw, V M, Camp, D, Votaw, E, Smith, M P, Kung, E, Malveaux, R, Watts, M, Huerkamp, D, Wu, E, Garcia, J M, Hoffman
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 38(1)
Fluorine-18-labeled 2 beta-carbomethoxy-3 beta-(4-chlorophenyl)-8-[-3-fluoropropyl) nortropane (FPCT) has been synthesized as a new dopamine transporter imaging agent.Fluorine-18 was introduced into 2 beta-carbomethoxy-3 beta-(4-chlorophenyl)-8-[-3-f
Autor:
D, Eshima, L A, Eshima, N M, Gotti, S C, Herda, C A, Algozine, T G, Burris, J P, Vansant, N P, Alazraki, A T, Taylor
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 37(9)
There has been a resurgence in the use of lymphoscintigraphy for the external detection of lymph nodes for metastatic melanoma and breast tumors. Technetium-99m-antimony trisulfide colloid was the radiopharmaceutical developed for this procedure and
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 36(9)
Because commercially available camera-based methods are not optimized, they fail to account for dose infiltration, table attenuation and correspondence between time of injection and starting the camera. We have developed a more optimized technique to
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 35(7)
To aid in the design of an improved 99mTc-labeled renal agent, several new [99mTcO(MAG3)]2- analogs were synthesized to determine the effects of varying the position and chemical form of the terminal charged group on renal clearance.Clearance, extrac